Trials / Completed
CompletedNCT00595270
Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 349 (actual)
- Sponsor
- Valneva Austria GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study investigates the long term persistence the Japanese encephalitis vaccine IC51 and the need of a booster dose
Detailed description
This is an open label, non-randomized multi-center phase 3 follow-up study. All volunteers having completed trial IC51-304 (NCT00595790) will be enrolled into this trial at 2 sites
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | IC51 |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2007-09-01
- Completion
- 2009-04-01
- First posted
- 2008-01-16
- Last updated
- 2014-03-07
- Results posted
- 2014-03-07
Source: ClinicalTrials.gov record NCT00595270. Inclusion in this directory is not an endorsement.